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Abstract.  The distribution, supramolecular form, and 
arrangement of collagen types I and V  in the chicken 
embryo corneal stroma were studied using electron 
microscopy, collagen type-specific monoclonal anti- 
bodies, and a  preembedding immunogold method. 
Double-label immunoelectron microscopy with colloi- 
dal gold-tagged monoclonal antibodies was used to 
simultaneously localize collagen type I and type V 
within the chick corneal stroma. The results defini- 
tively demonstrate, for the first time, that both colla- 
gens are codistributed within the same fibril. Type I 
collagen was localized to striated fibrils throughout the 
corneal stroma homogeneously. Type V  collagen could 
be localized only after pretreatment of the tissue to 
partially disrupt collagen fibril structure. After such 
pretreatments the type V  collagen was found in 
regions where fibrils were partially dissociated and not 
in regions where fibril structure was intact. When 
pretreated tissues were double labeled with antibodies 
against types I and V  collagen coupled to different size 
gold particles, the two collagens colocalized in areas 
where fibril structure was partially disrupted.  Antibod- 
ies against type IV collagen were used as a  control 
and were nonreactive with fibrils. These results indi- 
cate that collagen types I and V  are assembled to- 
gether within single fibrils in the corneal stroma such 
that the interaction of these collagen types within het- 
erotypic fibrils masks the epitopes on the type V  col- 
lagen molecule. One consequence of the formation of 
such heterotypic fibrils may be the regulation of cor- 
neal fibril diameter, a  condition essential for corneal 
transparency. 
T 
HE structure of collagen fibrils, the grouping of fibrils 
into bundles,  and the organization of fibril bundles 
within the stroma are all important in the determina- 
tion of extracellular matrix structure and function. The cor- 
neal stroma is a highly organized connective tissue in which 
the rigid control of fibril diameter and the precise arrange- 
ment of the collagen fibrils is essential for optical trans- 
parency (9).  Corneal collagen fibrils have a  monotony of 
small diameter fibrils (•25  nm) with a constant center to 
center spacing. The fibrils are further organized into ortho- 
gonal lamellae (3, 18-20, 45, 46). This uniformity and order 
at all levels of matrix architecture makes the corneal stroma 
an ideal tissue for studies on the in situ regulation of collagen 
fibrillogenesis. 
Collagen fibril formation is a complex process that is regu- 
lated by a number of  different factors, including: the collagen 
type or types present (2,  37),  the sequence and extent of 
propeptide processing (14, 15,  38),  interactions with other 
matrix components (7, 41), as well as a direct involvement 
of the cells (3, 4, 45). The collagen composition, distribution 
of collagen types, and fibril organization are characteristic 
of different connective tissues. The earliest corneal anlagen 
in the embryonic chicken is the primary stroma, an acellular 
orthogonal fibrillar meshwork composed of collagen types I 
and II, produced by the corneal epithelium (20, 21, 30). This 
is invaded by mesenchymal cells which deposit a  matrix, 
termed the secondary stroma. With the migration of fibro- 
blasts into the primary corneal stroma types I, V, and VI col- 
lagen are found throughout the secondary or mature corneal 
stroma (5,  13, 20, 29-32).  In the secondary stroma, type I 
collagen is the predominant collagen, with types V and VI 
contributing quantitatively less. However, the content of type 
V  collagen in the corneal stroma is relatively high when 
compared with other tissues containing predominantly type 
I collagen such as sclera, tendon, dermis, and bone (6, 8, 10, 
11,  16, 23, 26, 47, 50). 
Immunocytochemical studies of the chick cornea using 
anti-collagen monoclonal antibodies have demonstrated that 
type I collagen is distributed throughout the corneal stroma 
(5, 13, 30-32). In contrast, type V collagen could not be de- 
tected unless normal collagen fibrillar structure was dis- 
rupted with agents such as dilute acid or guanidine-HC1, or 
when the type I collagen was removed by digestion with ver- 
tebrate collagenase. After such treatments type V collagen, 
like type I collagen, could be detected uniformly throughout 
the stroma (13, 30-32, 49). 
In addition, fibril disruption by temperature manipulation 
of lathyritic corneas in which the collagen molecules have re- 
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epitopes on the type V collagen within the stroma (5, 13, 30). 
In these studies, the in ovo administration of the lathyro- 
gen,  ffaminopropionitrile ([IAPN), ~ was  used to  prevent 
the formation of covalent cross-links through the inhibition 
of  the enzyme lysyl oxidase (44). In such embryos, the newly 
formed collagen fibrils have a structure that is sensitive to 
temperature  manipulation.  In  such  tissues,  normal  fibril 
structure is maintained at 37~  while at 4~  the fibrils dis- 
sociate.  This dissociation of fibril  structure in the cold can 
be partially reversed by returning the tissue to 37~  (27, 28, 
48). We observed that when immunohistochemical staining 
was done on such tissues at 37~  there was no reactivity for 
type V collagen while at 4~  reactivity was observed. 
These results indicated that the helical epitopes on the type 
V  molecule recognized by the two monoclonal antibodies 
used are masked within the corneal stroma. A structural ar- 
rangement for fibrils in which type I collagen molecules are 
responsible for the antigenic masking of the type V collagen 
is suggested by the observation that digestion of tissues with 
vertebrate collagenase which degrades type I collagen but 
not type V, also will unmask the type V epitopes (13, 15, 30). 
Fitch et al.  (Fitch, J.  M., D.  E.  Birk, A.  Mentzer, R. A. 
Hasty, C. Mainardi, and T. E Linsenmayer, manuscript sub- 
mitted for publication) also have demonstrated that type V 
collagen is not hydrolyzed by a type V-specific collagenase 
unless fibrillar structure is disrupted. 
In the present study, double-label immunoelectron micros- 
copy with colloidal gold-tagged collagen type-specific mono- 
clonal antibodies was used to simultaneously localize colla- 
gen type I and type V within the fibrils of the chick corneal 
stroma. The results definitively  demonstrate for the first time 
that both collagens are codistributed within the same colla- 
gen fibril and that these fibrils are,  therefore, heterotypic 
structures. 
Materials and Methods 
White leghorn chicken embryos were incubated at 37.5~  in a humidified 
atmosphere and staged according to Hamburger and Hamilton (17). Ena- 
bryos were made lathyritic by the injection of 0.1 ml 13-aminopropionitrile 
fumarate (13APN; Sigma Chemical Co., St. Louis, MO) in PBS on days 8, 
9, and 10. Concentrations of 1.0 mg/ml on day 8,  1.5 mg/ml on day 9, and 
3.0 mg/ml on day 10 were used. The embryos were sacrificed on day 11 with 
a viable yield of 40-60%. 
Antibodies 
Two different monoclonal antibodies against type V collagen, V-AB12 and 
V-DH2 (32); two different monoclonal antibodies against type I collagen, 
I-BA1 and I-1B6 (33,  34); as well as two different antibodies against type 
IV collagen, IV-IIB12/C2  and IV-IAS/HSG8  (12, 36) were used in these 
experiments. These collagen type-specific antibodies have been character- 
ized previously and show no cross-reactivity with any other known colla- 
gen. They also are species specific and conformation dependent. In most 
experiments described, the two different type V-specific monoclonal anti- 
bodies, V-AB12 and V-DH2, were mixed to increase the observed labeling. 
These antibodies react with different epitopes; however, the epitopes occur 
at the same axial location along the helical region of the type V molecule, 
nm'from one end (30). 
Preembedding lmmunoelectron Microscopy 
Lathyritic or normal corneas were dissected from staged embryos, rinsed 
in PBS, incubated with 10% DMSO for 30 min, embedded in OCT Com- 
pound (Tissue Tek,  Miles Laboratories, Inc., Naperville, IL), and frozen 
1. Abbreviation  used in this paper:  [3APN,  ~aminopropionitrile. 
in liquid nitrogen. Sections were cut on a cryostat at 10 ~tm and picked up 
onto albumin-coated slides (5). 
To unmask the type V epitopes, the sections were incubated in PBS at 
4"C for 9-24 h depending on the experiment. Controls were incubated at 
370C for the same times. Fixation was with 4% paraformaldehyde in PBS, 
pH 7.4 for 15 min at 40C. The sections were washed three times in PBS and 
incubated in PBS with sodium borohydride (50 mg/100 ml) for 60 min at 
4~  to reduce any free aldehydes (35).  In some cases, the tissues were 
digested with 500 U/ml ovine testicular hyaluronidase (Sigma Chemical 
Co.) in PBS at 37"C for 30 min to facilitate penetration of the antibody-gold 
complexes. 
The sections were washed several times in PBS and blocked in 2 % nor- 
mal goat serum for 2 h at 4"C followed by PBS with 1% BSA, 0.05 % Tween 
20, 0.05 % sodium azide, pH 7.3. The sections were then incubated overnight 
at 40C with gold-conjugated antibody.  The antibodies were diluted in PBS 
with 1% BSA and 0.05 % Tween 20 and centrifuged for 5 min in a microfuge 
(Brinkmann Instruments Co., Westbury,  NY). Antibodies conjugated to 5 
nm gold were used at 0.20-0.30  OD~0o units while the antibodies con- 
jugated to 10 nm gold particles were used at 0.30-0.40 OD600 units. After 
incubation, the sections were washed five times over 1 h with PBS/0.05% 
Tween, three times with PBS, and rinsed with 0.1  M cacodylate buffer. 
The sections were fixed in 2.5% glutaraldehyde, 0.1  M cacodylate pH 
7.4 for 1 h followed by postfixation in 1% OsO4 in 0.1 M cacodylate buffer 
for 1 h. The tissues were dehydrated in a graded ethanol series. In some 
cases the corneal stroma was stained en bloc with ethanolic uranyl acetate 
which significantly enhances the staining of the partially dissociated colla- 
gen fibrils. After postfixation in osmium, the tissues were washed with caco- 
dylate buffer, and dehydrated through 30 and 50% ethanol. At this stage the 
tissues were transferred to 2% uranyl acetate in 50% ethanol and en bloc 
stained with filtered ethanolic uranyl acetate for 1 h at 4~  Dehydration was 
continued through 70, 85, 95, and 100% ethanol, propylene oxide, and the 
sections were embedded in Epon-Araldite. The embedded sections were 
mounted on epoxy cylinders and polymerized. The sections were "pepped 
off" by gently rocking the epoxy cylinder after placing the polymerized slide 
on a  100~  hot plate for 15 s (5). 
Electron Microscopy 
For transmission electron microscopy, sections were cut with a pale gold 
interference  color, picked up onto mesh grids, stained with 2 % aqueous ura- 
nyl acetate followed by 1% phosphotungstic acid pH 3.2.  Sections were ex- 
amined and photographed using a Philips 420 transmission electron micro- 
scope. 
Preparation of Colloidal Gold-conjugated Antibodies 
Colloidal gold suspensions containing particle sizes of 5 and 10 run were 
purchased from Janssen Life Sciences Products (Piscataway, NJ). The gold 
colloid preparations had no overlap of particle distributions. The gold par- 
ticles were coated with affinity-purified antibodies using a procedure modi- 
fied from Roth (40) and Slot and Geuze (43). The antibodies were dialyzed 
overnight against 10 mM phosphate buffer with 0.05 % sodium azide pH 8.3, 
a pH slightly greater than the isoelectric point of the antibody. The antibod- 
ies, centrifuged at 100,000 g for 60 rain to remove aggregates, were added 
to the colloidal gold suspension. 
The lowest concentration of antibody which fully protects the colloidal 
gold particles from precipitating in a high ionic strength solution plus 10% 
was chosen for coating the gold. The stock colloidal gold solution was ad- 
justed to pH 8.3 with 0.2 M K2CO3 and the antibody in 10 mM phosphate 
buffer of the same pH was added dropwise to the colloidal gold solution, 
over a 30-s period, with gentle stirring. After 5 rain of stirring it was deter- 
mined if an aliquot was fully protected against precipitation by 1 M NaCI. 
If so, 0.3 ml of 5% polyethylene glycol (15,000-20,000  tool wt), 2.0 ml of 
PBS solution containing 1.0 M NaCI, and 3.0 ml of PBS containing 1% BSA 
were added.  Large aggregates were removed by centrifugation (20 rain, 
5,000 g). The supernatant was centrifuged for 45 rain at 34,000 rpm for 
5 nrn gold or 25,000 rpm for 10 nm gold in a rotor (type 50; Beckman Instru- 
ments, Inc., Palo Alto, CA). The pellet was resuspended in PBS, 0.1% BSA, 
0.05%  Na azide pH 8.3, applied to a  10%-35% glycerol gradient in PBS 
with 0.1% BSA, and centrifuged (45  rain at  125,000 g  for 5 nm gold or 
50,000 g for 10 nm gold; SW-.41 Ti rotor; Beckman Instruments, Inc.). The 
upper one-third to one-half of the gradient contained antibodies coupled to 
the single gold particles as determined by transmission electron microscopy. 
The fractions from the gradient containing antibody coupled to single gold 
particles were washed by centrifugation in PBS, 0.1% BSA, 0.05%  Na azide 
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lagen  types  I  and  V  in  the 
lathyritic  cornea  pretreated 
at 4~  or 37~  Chicken em- 
bryos  were  made  lathyritic 
beginning on day 8 of devel- 
opment by the in ovo adminis- 
tration of 13APN. The corneas 
were dissected on day 11 and 
cryostat sections were cut. Sec- 
tions  from  the  same  cornea 
were incubated for 15 h at ei- 
ther 4~  a  condition where 
fibril structure is partially  dis- 
rupted (A, C, and E) or 37~ 
a condition where fibril struc- 
ture is maintained (B, D, and 
F). The sections were fixed in 
paraformaldehyde  and  incu- 
bated  with  monoclonal  anti- 
bodies coupled directly to ei- 
ther 5 or 10 nm colloidal gold 
particles. A and B were incu- 
bated  with  monoclonal  anti- 
bodies against type I collagen 
coupled to 10 nm gold; C and 
D were incubated with mono- 
clonal antibodies against type 
V  collagen coupled to 5  nm 
gold; and E and F were incu- 
bated  with  monoclonal  anti- 
bodies against type IV colla- 
gen coupled to 5 nm gold. (A 
and B) The anti-type I mono- 
clonal antibodies label all of 
the  fibrils present.  (C)  The 
anti-type V monoclonal anti- 
bodies label only those lathy- 
ritic  fibrils  whose  structure 
has  been  partially disrupted 
by the pretreatment with cold 
PBS  (solid arrows).  Nondis- 
rupted  fibrils,  presumably 
formed before  the  inhibition 
of cross-linking (open arrows) 
are not labeled by the antibod- 
ies  against type V  collagen. 
(D) All of the fibrils maintain 
their  structure  at  37~  and 
there  is  no  labeling  of  the 
fibrils with antibodies against 
type V  collagen.  (E and  F) 
The antibodies against type IV 
collagen,  which  is  normally 
confined  to  basement  mem- 
branes,  show  no  reactivity. 
Bar,  100 nm. 
pH 7.4 (as described above). The washed fractions were diluted to a concen- 
tration corresponding to 0.60D60o unit and stored. 
Results 
Monoclonal antibodies against collagen types I  and V  were 
used  individually or  simultaneously in  a  series of single- 
and double-label immunoelectron microscopic experiments. 
Both  normal  ll-d  chick  embryo  corneas  or  those  made 
lathyritic were used. In single-label experiments, all the stri- 
ated  collagen fibrils of tissue  sections  labeled with  gold- 
conjugated  antibodies  against type  I  collagen  were  deco- 
rated. The labeling of the fibrils was identical regardless of 
whether normal corneas (data not shown) or lathyritic cor- 
neas after pretreatment in PBS at either 37~  a condition in 
which fibril structure is maintained or 4~  a  condition in 
Birk et al. Collagen Types I and V Form Heterotypic Fibrils  1001 Figure 2. Colocalization  of collagen types I and V in the lathyritic cornea pretreated at 4~  Sections from lathyritic corneas were incubated 
in PBS for 15 h at 4~  a condition where fibril structure is partially disrupted, fixed in paraformaldehyde, and incubated simultaneously 
with two different monoclonal antibodies coupled directly to either 5 or 10 nm colloidal gold particles. A was incubated with monoclonal 
antibodies against type I collagen coupled to  10 nm gold and against type V collagen coupled to 5  nm gold particles; B was incubated 
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studied (Fig. 1, A and B). When antibodies specific for type 
V  collagen were used to label normal (data not shown) or 
lathyritic cornea sections pretreated in PBS at 37~  no reac- 
tivity was observed (Fig. 1 D). However, when lathyritic cor- 
neal sections were pretreated for 12 h  at 4~  in PBS, the 
fibrils that had become partially dissociated were now heav- 
ily labeled with the anti-type V collagen antibodies (Fig.  1 
C). The fibrils that maintained their structural integrity re- 
mained unlabeled presumably because they had been formed 
before administration of the lathyrogen. In control prepara- 
tions reacted with antibodies directed against type IV colla- 
gen, a type thought to be restricted to basement membranes, 
the striated stromal fibrils were unreactive under all condi- 
tions ~ig.  1, E  and F). 
To localize simultaneously collagen type I and type V, a 
series of  double-label experiments were performed. In these 
experiments,  lathyritic corneal sections were subjected to 
pretreatment in PBS at 4~  for 12 h. The sections were then 
double labeled with anti-type I monoclonal antibodies con- 
jugated to 10 nm gold particles and anti-type V monoclonal 
antibodies coupled to 5 nm gold particles (Fig. 2 A). As can 
be seen in Fig. 2 A, all fibrils were labeled with the anti-type 
I collagen antibody coupled to 10 nm gold particles. How- 
ever, only those fibrils whose structure had been partially 
disrupted  by  the  pretreatment  at  4~  also  demonstrated 
labeling with the 5 nm particles coupled to the type V colla- 
gen  antibody.  The codistribution of both  labels  on  such 
fibrils indicates that they are composed of both type I and 
type V collagen molecules. 
As a control for possible nonspecific interactions between 
the different size colloidal gold particles, double-label ex- 
periments were done with one size gold particle coupled to 
antibodies against either type I or type V collagen and the 
other size gold particle coupled to an antibody against type 
IV  collagen.  In  such  combinations  only  the  antibodies 
against the type V (Fig. 2 B) or type I (Fig. 2 C) collagen 
labeled the stromal fibrils, so the labeling appeared identical 
to that seen in the single label experiments with antibodies 
against types I or V collagen. As a further control for these 
double-label experiments, sections were examined in which 
both 5 and 10 nm gold particles were coupled to antibodies 
against type IV collagen. In these cases, the collagen fibrils 
had essentially no label (data not shown). 
Double-label immunoelectron microscopic localization of 
collagen types I and V also was performed on lathyritic cor- 
neas pretreated at 37~  (Fig. 3, A, C, and E) and on normal 
corneas (Fig. 3, B, D, and F). The results confirm the single- 
label studies. The fibrils labeled with the antibodies against 
type I collagen, but demonstrated, little, if any reactivity for 
type V 2 (Fig. 3, A and B). Controls also were performed in 
which one of the antibodies was replaced with anti-type IV 
collagen antibody (Fig. 3, C-F). When these different com- 
binations were used on either normal or lathyritic corneas 
pretreated at 37~  the only fibrillar labeling was for type I 
collagen. 
To characterize further the effect  of low temperature on the 
structure of lathyritic collagen  fibrils,  we determined the 
time course of unmasking of the epitopes of type V collagen. 
Adjacent  sections  from  the  same  lathyritic  cornea  were 
pretreated at 4~  in PBS for 9,  12, 15, and 18 h followed by 
double-label immunolocalization of collagen types I and V. 
At all time points, all fibrils labeled with the antibody against 
type I  collagen.  However, reactivity for type V  collagen 
could not be conclusively detected until after 12 h of  pretreat- 
ment (Fig. 4 A). In sections pretreated for longer periods of 
time there was a progressive increase in the amount of label 
against type V collagen (Fig. 4, B and C). The increase in 
the labeling was correlated with an increase in the number 
and extent of the dissociated collagen fibrils. 
To  exclude  the  possibility  that  the  secondary  corneal 
stroma might have two populations of collagen fibrils, one 
containing type I collagen and heterotypic fibrils containing 
collagen types I  and V,  very lathyritic corneas were dis- 
sociated at 4~  and labeled with antibodies against either 
type I or type V collagen (Fig. 5). In these experiments all 
of the fibrils were labeled with antibody against type I col- 
lagen (Fig. 5 A) and most of the fibrils were labeled with 
antibodies specific for type V collagen (Fig. 5 B). The pre- 
treatment protocol used with these very lathyritic fibrils dis- 
sociated all  susceptible fibrils.  A  small proportion of the 
fibrils did not label with antibody against type V collagen 
presumably because they were formed before the inhibition 
of covalent cross-linking. 
To determine whether, within these fibrils the type V colla- 
gen was arranged in the "quarter-staggered" array, the distri- 
bution of the  gold particles was  determined from micro- 
graphs similar to those presented in Figs.  1 C and 2 B. As 
can be seen in Fig. 6 B, the label for type V occurred with 
a clear periodicity of  65 nm. The relative frequency distribu- 
tion of  these measurements were nearly identical to those de- 
termined for type I  collagen (Fig. 6 A). This periodic ar- 
rangement of  type V collagen provides evidence that the type 
V molecule can fit in a fibrillar packing arrangement along 
with type I collagen. 
2.  The labeling for type V collagen in normal and lathyritic corneas 
pretreated at 37~  was often slightly  above  the type IV control  level. This 
suggests that a small penion of the type V collagen  molecules  may be ex- 
posed on a fibril surface,  however,  there  was never  enough  label  to conclude 
this with certainty. 
with monoclonal antibodies against type V collagen coupled to 5 nm gold and against type IV coupled to 10 nm colloidal gold; and C 
was incubated with monoclonal antibodies against type I coupled to 10 nm particles and antibodies against type IV collagen coupled to 
5 nm gold. (A) Both collagen types I and V are found within a single fibril as demonstrated by the decoration of fibrils with both 5 and 
10 nm gold particles. Most of the fibrils are labeled with antibodies against type I collagen coupled to 10 nm gold, while only those fibrils 
whose structure has been partially disrupted by the pretreatment with cold PBS are labeled with the antibodies against type V collagen 
coupled to 5 nm gold (arrows). In some cases the fibril is so dissociated that the labeled structure is difficult to identify. (B) The compact 
fibrils (open arrowheads) are not decorated with 5 nm gold particles coupled to anti-type V collagen. Those fibrils formed in the presence 
of 13APN, and therefore not fully cross-linked, have been partially dissociated by the cold treatment, and are labeled with antibodies specific 
for type V collagen. Note the absence of 10 nm gold particles conjugated to anti-type IV collagen. (C) All fibrils are labeled by the antibodies 
against type I collagen. Note the absence of 5 nm gold particles which were conjugated to anti-type IV collagen. The periodicity of  collagen 
type I (small arrows) is readily apparent in this panel. Bar, 100 nm. 
Birk et al. Collagen Types I and V Form Heterotypic Fibrils  1003 In summary, these data indicate that collagen types I and 
V are present within the same fibril. A staggered relationship 
of collagen type I with type V within these heterotypic fibrils 
results in masking of the helical determinants recognized by 
the two different monoclonal antibodies against type V col- 
lagen. 
Discussion 
The data presented here represent the first direct demonstra- 
Figure  3.  Colocalization  of 
collagen types I and V in the 
lathyritic  cornea pretreated  at 
37~  and  nonlathyritic  cor- 
neas.  Sections  from lathyritic 
corneas (A, C, and E) or non- 
lathyritic  corneas (B, D,  and 
F) were incubated  in PBS for 
15 h at 37~  The sections were 
fixed  and  incubated  simulta- 
neously  with  two  different 
monoclonal  antibodies  cou- 
pled  directly  to  either  5  or 
10 nm colloidal gold particles. 
A and B were incubated  with 
monoclonal antibodies against 
type  I  collagen  coupled  to 
10 nm gold and against type V 
collagen coupled to 5 nm gold 
particles;  C  and  D  were  in- 
cubated with monoclonal anti- 
bodies  against  type V  colla- 
gen coupled to 5 nm gold and 
against type IV coupled to 10 
nm colloidal  gold; and E and 
F were incubated  with mono- 
clonal antibodies  against type 
I  coupled to  10 nm particles 
and antibodies against type IV 
collagen coupled to 5 nm gold. 
In nonlathyritic corneas and in 
lathyritic  tissues  pretreated  at 
37~  collagen fibril structure 
is  maintained  and  therefore 
type V collagen is not labeled. 
(A and B) Most of the fibrils 
are  labeled  with  antibodies 
against  type  I  collagen  cou- 
pled to 10 nm gold. Note the 
relative  absence  of 5 nm gold 
particles coupled to type V an- 
tibodies.  It is a common ob- 
servation that the type V label 
is slightly above that seen for 
the type IV control. (Cand D) 
The  compact  fibrils  are  not 
decorated with 5 nm gold par- 
ticles  coupled to anti-type V 
collagen  or 10 nm gold parti- 
cles coupled to anti-type IV 
antibodies.  (E and F) All fi- 
brils  are labeled  by the anti- 
bodies against type I collagen. 
Note the absence of 5 nm gold 
particles  which  were  conju- 
gated  to  anti-type  IV  colla- 
gen. Bar,  100 nm. 
tion that collagen fibrils in situ are composed of more than 
one collagen type. We have established by double-label im- 
munoelectron microscopy using collagen type specific mono- 
clonal antibodies directly coupled to different size colloidal 
gold particles that in the avian cornea, both collagen types 
I and V are present within the same fibril. Determination of 
this colocalization of type V collagen with type I collagen re- 
quired pretreatment  of the tissue to partially  disrupt  fibril 
structure, indicating that the epitopes recognized by the type 
The Journal of Cell Biology, Volume 106, 1988  1004 Figure 4.  The time course of colocalization of collagen types I and V in the lathyritic cornea pretreated  at 4~  Chicken embryos were 
made lathyritic beginning  on day 8 by the in ovo administration  of ~APN and dissected on day 11 of development.  Sections from the same 
cornea were pretreated  in PBS at 4~  for 12 (A), 15 (B), or 18 (C) h, a procedure that progressively disrupts fibril structure.  Double im- 
munochemical-labeling  experiments were done to localize collagens type I and V simultaneously. Sections were incubated simultaneously 
with monoclonal antibodies against type I collagen coupled to  10 nm gold and against type V collagen coupled to 5 nm gold particles. 
Both collagen types I and V are found within a single fibril as demonstrated by the decoration of fibrils with both 5 and 10 nm gold particles. 
Most of the fibrils are labeled with antibodies against type I collagen coupled to 10 nm gold while only those fibrils whose structure has 
been partially disrupted by the pretreatment with cold PBS are labeled with the antibodies against type V collagen coupled to 5 nm gold. 
The amount of type V label increases with time in the cold and is associated with an increase in number and extent of dissociated  fibrils. 
Bar,  100 nm. Figure 5. Heterotypic fibrils predominate in the secondary stroma. Lathyritic lid corneas were dissected, cryostat sections were cut, and 
the sections were incubated for 18 h at 4~  to disrupt all susceptible fibrils. The pretreated sections were fixed and incubated with monoclo- 
hal antibodies coupled to 10 nm colloidal gold particles. (A) The anti-type I monoclonal antibodies label all of the fibrils present. (B) 
The anti-type V monoclonal antibodies label most of  the fibrils present. A few nondisrupted fibrils, presumably formed before the inhibition 
of  cross-linking (arrows), are not labeled by the antibodies against type V collagen. The labeling of most of  the fibrils in both fields indicates 
that most, if not all, corneal fibrils are heterotypic. Bar, 500 nm. 
V  collagen-specific monoclonal antibodies are unavailable 
to the antibodies within an intact collagen fibril. 
The temperature manipulation of  lathyritic fibrils was used 
to partially disrupt and therefore 'Mnmask"  the type V epi- 
topes. Types I and V collagen molecules are assembled as 
heterotypic fibrils with the type I  molecules blocking the 
type V epitopes, helical determinants on the type V mole- 
cule. Collagen fibrils with a normal complement of covalent 
intermolecular cross-links have a stable structure over a wide 
range of physiological temperatures. Lathyritic fibrils, deft- 
cient in intermolecular cross-links, are stable at 37~  but at 
0-4~  the fibril dissociates exposing molecules within the 
fibril (27, 28, 48). As this occurs the epitopes on the type V 
collagen molecule become unmasked. 
The labeling  of collagen fibrils with antibodies  against 
type V  collagen requires the disruption of fibril structure. 
The degree of fibril disruption observed is dependent on the 
method used  to  disrupt  fibril  structure  (lathyrism,  dilute 
acid, collagenase) and the time course and/or concentration 
used for disruption. Morphologically, fibrils labeled with an- 
tibodies against type V  collagen vary from no discernable 
change in fibril structure, to fibrils with a loss of characteris- 
tic striations, to thin filaments with no periodicity. This is not 
dependent on the stage of  development  but rather on the con- 
ditions and time used to disrupt fibril structure. 
As a  method to dissect collagen fibrils, lathyrism offers 
several other advantages. Within a tissue, it produces at least 
two  distinct  populations  of fibrils:  those  that  are  highly 
cross-linked, presumably due to their early deposition, and 
those  that  do not have  a  full complement of cross-links. 
Thus, the highly cross-linked collagen can serve as internal 
controls  for  the  ones  whose  structure  can  be  thermally 
manipulated.  Secondly, the unmasking  by pretreatment at 
4~  is  almost  totally  reversible  when  the  sections  are 
returned to 37~  (13, 30; unpublished observations). Finally, 
adjacent sections treated at 4~  versus those treated at 37~ 
serve as controls for one another. 
We used ll-d corneas in this study rather than 17-d corneas 
which we had  used previously (5).  The younger corneas 
were chosen for two reasons: there is a larger proportion of 
lathyritic fibrils sensitive to temperature manipulation in the 
younger corneas; and the younger corneas have not com- 
pacted and therefore there is more space around fibril bun- 
dies so the penetration of antibody-gold conjugates does not 
present a problem. We found no differences in the secondary 
corneal stroma in these two developmental stages. 
Like most dense stromal connective tissues,  the cornea 
contains predominantly type I collagen (20). However, un- 
like other tissues containing predominantly type I collagen, 
the  corneal  fibrils  have  uniformly small  diameters  (•25 
nm). This unique morphology may be related to the fact that 
in several species, it has been shown that the corneal stroma 
contains significantly more type V collagen than do other tis- 
sues whose stromal matrix collagen is predominantly type 
I  (8,  10,  11,  16, 23, 47,  50).  Immunohistochemical studies 
have demonstrated that type V  collagen is distributed uni- 
formly throughout the corneal stroma as an interstitial colla- 
gen (5,  13,  30-32,  49).  These biochemical and  immuno- 
histochemical observations suggest that type V collagen may 
interact with type I  collagen to regulate corneal fibril di- 
ameter.  The  current demonstration that  the  two  collagen 
types physically interact,  and  that  type V  collagen  is  ar- 
ranged in the quarter-staggered array typical of fibrillar col- 
lagens, further strengthens this argument. 
The Journal of Cell Biology,  Volume 106, 1988  1006 Figure  6.  Periodicity  of monoclonal  antibody-labeled  collagen 
types I and V. The periodicity of collagen type I and type V was 
determined by measuring the distance between adjacent gold parti- 
cles on well-defined  collagen fibrils. The measurements were done 
from micrographs similar to Fig. 1, A-C and Fig. 2, B and C and 
were normalized to the 67-nm macroperiod of the type I collagen 
fibril.  (A) The relative frequency distribution of type I collagen 
measurements is shown. As expected, labeling with the monoclonal 
antibody against type I collagen demonstrates a clear 67-nm perio- 
dicity. (B) The relative frequency distribution of type V collagen 
measurements is presented. The labeling of type V collagen with 
monoclonal antibodies against type V collagen exhibits a periodic- 
ity identical to that of  type I collagen. The arrows indicate the mac- 
roperiod of type I collagen and two times the macroperiod.  The 
peaks bounded by the asterisk have a range of  47-86 nm and a mean 
of  66 + 7.5 nm (+SD) for type I collagen while for type V collagen 
the range is 39-79 nm and the mean is 65  :t: 7.5 nm (+SD). 
There are a number of ways in which a quantitatively mi- 
nor collagen type could function to regulate fibril diameter. 
Type V collagen may inhibit the lateral growth of the corneal 
fibrils because of its longer helix (42) and/or because of the 
persistence of a terminal globular domain (6,  11) even after 
assembly into a  fibril. These features may permit the co- 
assembly of type V collagen with type I collagen only until 
a  certain "critical" type V  concentration is  reached, after 
which the continued addition of type I collagen is inhibited 
by the 'nonfitting' type V  molecule. Another possibility is 
that type V collagen forms thin core filaments which serve 
as nucleation sites for type I collagen assembly. The pres- 
ence of more nucleation sites for a given quantity of type I 
collagen might result in smaller fibril diameters than in a tis- 
sue where there were fewer nucleation sites for the same 
amount of type I collagen. Further elucidation of  the physical 
arrangement of type I and type V within fbrils is required 
to distinguish between these and other possible regulatory 
mechanisms. 
In vitro studies have demonstrated that type V collagen in- 
teracts (1; Birk, D. E., J. M. Fitch, J. E  Babiarz, and T. E 
Linsenmayer, manuscript in preparation) or copolymerizes 
(Birk, D.  E., J.  M.  Fitch, J.  E  Babiarz, and T. E  Linsen- 
mayer, manuscript in preparation) with type I  collagen to 
produce  fibrils  with  smaller  diameters.  Increasing  the 
amount of type V collagen available progressively decreases 
the  mean  fibril diameter.  These studies  along  with  other 
studies involving the copolymerization of collagen types I 
and  III  in  vitro (25)  implicate heterotypic assembly as  a 
general regulatory mechanism in the control of fibril struc- 
ture.  In  vivo  immunochemical  localization  studies  have 
shown that collagen types I and II (21, 30), types II and IX 
(39), and types I and III (24) are possibly present as hetero- 
typic fibrils. A covalent peptide of collagen types I and III 
was isolated which further supports this conclusion (22). We 
believe it likely that the various collagen types present within 
a tissue are responsible, in a major way, for the control of 
tissue architecture. For example, type I collagen generally 
forms thicker fibrils than types II and III collagen both in tis- 
sues (37) and in reassembly studies in vitro (2, 25). Type V 
collagen has the ability to form thin filaments with no appar- 
ent periodicity (6) or to interact with type I collagen as stri- 
ated fibrils (1; Birk, D. E., J.  M.  Fitch, J.  E  Babiarz, and 
T. E  Linsenmayer, manuscript in preparation). With this in 
mind it is possible that varying the major collagen type pres- 
ent and/or modulating the proportions of the various colla- 
gen types being coassembled a large number of fibril and tis- 
sue architectures would be possible. 
We have shown that collagen types I and V copolymerize 
during corneal fibrillogenesis. There are a number of possi- 
ble ways in which these two distinct collagen types could be 
arranged structurally to form a heterotypic fibril. For exam- 
ple, type V collagen could form a core filament and type I 
collagen  molecules polymerize along these preformed fi- 
brils. Another possibility is that type I and type V collagen 
could form as  alternating  layers or  some other patterned 
manner.  Also, there could be a dispersed incorporation of 
type V collagen with type I during polymerization either as 
individual molecules or as some intermediate subassembly. 
Finally, type V collagen might even be present on the surface 
of a type I fibril, but have specific epitopes on the molecule 
which are unavailable. At present, the data can not definitely 
rule out any of these or other possibilities. 
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